Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Schaerbeek – page 47

1 961 clinical trials in Schaerbeek, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Schaerbeek at a glance
1 961
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 961 trials in Schaerbeek

Open in trial search

Study on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Institut Gustave Roussy

Study on the Safety and Effectiveness of Baricitinib for Children Aged 1 to 17 with Juvenile Idiopathic Arthritis

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Baricitinib
  • Sponsor:Eli Lilly & Co.

Study on Long-Term Safety of Enzalutamide, Abiraterone, and Prednisolone for Patients with Prostate Cancer from Previous Enzalutamide Trials

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Astellas Pharma Global Development Inc.

Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Cyclophosphamide
  • Sponsor:Universitaetsklinikum Muenster AöR

Study on Posaconazole for Treating Fungal Infections in Children Under 2 Years

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Posaconazole
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Effects of Ficlatuzumab and Cetuximab for Adults with Recurrent or Metastatic HPV-Negative Head and Neck Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Aveo Pharmaceuticals Inc.

Study of Radium-224 in Patients with Advanced Ovarian, Fallopian Tube, or Peritoneal Cancer with Peritoneal Metastasis Undergoing Chemotherapy and Surgery

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:RADIUM-224 adsorbed in calcium carbonate microparticles
  • Sponsor:Oncoinvent ASA

Study on AVB-101 for Patients with Frontotemporal Dementia with Progranulin Mutations

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:AVB-101
  • Sponsor:Aviadobio Limited

Study on Diacerein 1% Ointment for Treating Generalized Epidermolysis Bullosa Simplex in Patients Aged 6 Months and Older

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Diacerein
  • Sponsor:Twi Biotechnology Inc.

Study of NVL-520 for Patients with Advanced ROS1-Positive Lung Cancer and Other Solid Tumors

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Zidesamtinib
  • Sponsor:Nuvalent Inc.

Study Comparing Pirtobrutinib and Ibrutinib for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Loxo Oncology Inc.

Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel or Stem Cell Transplant for Newly Diagnosed Multiple Myeloma Patients

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Emn Trial Office S.r.l. Impresa Sociale

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Schaerbeek

What the registry says about research in the country

01 Digestive System Diseases

In Schaerbeek, researchers are focusing on common gastrointestinal complaints such as functional dyspepsia, heartburn and reflux, aiming to improve patient outcomes through medication optimization.

  • Assessing de‑prescribing strategies for chronic proton pump inhibitors
  • Comparing on‑demand use versus alginate‑based alternatives
  • Evaluating patient‑centered approaches to reduce unnecessary medication

The trials seek to identify safer, effective ways to manage acid‑related disorders while minimizing long‑term drug exposure.

02 Virus Diseases

A parallel study in Schaerbeek targets viral infections of the oral cavity, specifically patients with frequent orofacial herpes infections.

  • Testing the efficacy of the antiviral candidate 2LHERP®
  • Measuring reduction in episode frequency over a 12‑month period
  • Improving quality of life for individuals prone to recurrent outbreaks

The goal is to determine whether the new treatment can significantly lower the number of herpes episodes compared with standard care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.